Wednesday, May 27, 2020 10:25:58 PM
As I said, had LP and friends paid upfront cash like many of us accredited investors, especially considering the amount of warrants involved, we would not have needed this latest loan financing which is actually deferred dilution. To be sure, additional financing will be required but who knows whether during the restrictive period, the SP will be higher engendering less dilution. NWBO's track record for guidance is embarrassingly poor.
Less than 2 months ago we had the warrant extension financing--where LP essentially obtained a free non-contingent extension-- and she now has the "balls" to go for another financing although not immediately dilutive.
And......NWBO's General Counsel is OK with this! I don't know where he gets his advice but other attorneys who I know believe as I do that at least on its face a case could be made for unjust enrichment, tortious conduct and even theft of company assets.
It is amazing that there are MB posters that condone this kind of conduct and essentially through their defense of it on MBs which are undoubtedly read by management encourage the continuance of this behavior.
In the absence of more persuasive explanations, this is shameless and over reaching greed and LP has significantly if not 100% de risked her " investment"
The science hopefully will come to the rescue but there is no doubt in my mind that management's behavior and lack of credibility had a lot to do with depressing the market value of the company. Here we get a good run, finally, and sure as clock work in the midst of the run, LP farts another financing. Incredible. I suppose some longs just don't know when they have been insulted.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM